What Is CPVT & What Causes It?
CPVT is a form of genetic heart disease. It is characterised by abnormal heart rhythms when stress hormones, in particular adrenaline or noradrenaline (also called catecholamines) are high. These are released when you exercise or experience intense emotion. Typically, these help to increase your heart and blood pressure so that your muscles get the extra oxygen they need when you are exercising or as a response to a stressful situation. However, if you have CPVT, this process doesn’t work in quite the same way.
Instead, your heart will beat more rapidly. It can beat so quickly that there is no time for blood to fill the heart before the next beat. This means that while your heart is technically pumping, sufficient blood is not being moved around your body. If left untreated, your heart may stop beating entirely, potentially leading to sudden arrhythmic death syndrome.
This arrhythmia (irregular heartbeat) is a result of mutations in your genes that control certain cardiac proteins. Mutations to these genes then affect how calcium moves through your heart, leading to extra calcium in your heart’s electrical system.
The electrical system lets your heart know when and how fast it needs to beat in order to pump blood around the body. With the extra calcium, it beats faster and more often, which can then lead to palpitations, loss of consciousness and even sudden death.
Specialists have carefully examined cases of CPVT to better understand which genes play a role in this heart condition. Presently, mutations in the genes RYR2, CASQ2, CALM1, CALM2, TECRL and TRD have been identified as causing CPVT, with mutations in RYR2 thought to be responsible for most cases of CPVT. However, other genes may also play a role in the condition, and we may learn more about these through research in the future
Like all genetic mutations, the mutations that cause CPVT can be inherited from your parents or they may spontaneously occur when you are conceived. CPVT, unlike many other genetic heart conditions, can be autosomal dominant or recessive. Autosomal dominant conditions only require one copy of the gene to be mutated to cause the disease, while recessive conditions need both copies of the gene to be faulty. CPVT is a unique case because of the different genes at play. For instance, if the RYR2 gene contains the mutation, the condition will be autosomal dominant. However, if the CASQ2 gene is affected, it typically is autosomal recessive.
As a result of these inheritance patterns, CPVT genetic testing becomes more important than ever. This is because it allows you to not only confirm a diagnosis of CPVT but understand exactly which gene is affected. You and your healthcare team can then use this information to more accurately predict who else in your family may have the condition, including the likelihood of your children inheriting it.